HCA Healthcare Inc. (HCA)
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HCA Healthcare Q1 Earnings Beat on Growing Patient Volumes
HCA continues to witness growth in reported and same-facility admissions. The company reaffirms 2025 guidance.
Compared to Estimates, HCA (HCA) Q1 Earnings: A Look at Key Metrics
The headline numbers for HCA (HCA) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HCA Healthcare (HCA) Beats Q1 Earnings and Revenue Estimates
HCA Healthcare (HCA) came out with quarterly earnings of $6.45 per share, beating the Zacks Consensus Estimate of $5.77 per share. This compares to earnings of $5.36 per share a year ago.
HCA Healthcare Tops Revenue Expectations
HCA Healthcare (HCA 1.64%), a prominent player in the healthcare sector, announced robust first-quarter results for 2025 on Friday, April 25, that surpassed market expectations. The company recorded an adjusted EPS of $6.45 for Q1 2025, exceeding the anticipated $5.75.
HCA Healthcare posts higher profit on strong demand for medical care
Hospital operator HCA Healthcare said on Friday its first-quarter profit rose nearly 9%, as more people underwent elective procedures and sought medical care due to a rise in flu cases.
HCA Healthcare to Report Q1 Earnings: Key Estimates to Note
HCA's first-quarter earnings are likely to have benefited from growing admissions.
Exploring Analyst Estimates for HCA (HCA) Q1 Earnings, Beyond Revenue and EPS
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for HCA (HCA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
Despite Regulatory Uncertainties, HCA Healthcare Looks Healthy
I believe HCA Healthcare is currently undervalued, especially after a recent 20.9% share price drop, making it a compelling 'buy' candidate. HCA Healthcare's financial performance has been solid, with revenue rising 5.7% year-over-year, driven by increased hospital traffic and higher revenue per admission. Despite mixed profitability metrics, management's forecast for 2025 shows expected revenue growth and higher profits, reinforcing my bullish stance.
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
2 Stocks to Buy if You're Worried About a Recession
Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies.
